Podcasts about prescription drugs

David Bahnsen fills in for Brian Szytel with a Daily Recap recorded shortly before the close as markets trade higher (Dow up ~300, S&P up nearly 1%, Nasdaq up over 1%) and notes upcoming Nvidia earnings. He focuses on economic takeaways from the State of the Union rather than politics, highlighting the lack of new affordability proposals as potentially market-friendly. He says Medicaid drug price controls were reiterated but have little market impact due to low passage odds, and that pharma has largely navigated tariff threats already. He reviews proposals for government-matched quasi-401(k) plans for lower-income Americans, requiring hyperscalers to fund their own power needs, and an unrealistic idea of tariffs replacing income taxes. He supports banning congressional stock trading and notes omissions on credit-card rate caps and 2026 tax-cut reconciliation, while flagging a call to ban institutional ownership of residential real estate. 00:00 Market Snapshot Setup 00:36 State of the Union Focus 01:12 Affordability and Policy Restraint 02:15 Prescription Drugs and Pharma 03:25 New Savings Plan Proposal 03:42 AI Data Centers and Power 04:17 Tariffs and Tax Reality Check 04:45 Congress Stock Trading Ban 05:04 What Wasn't Said and Housing 05:48 Wrap Up and Sign Off Links mentioned in this episode: DividendCafe.com TheBahnsenGroup.com

During Trumps State of the Union, he talked about lowering the cost of medicine, but can it really happen?

In 2019, Maryland became the first state in the nation to establish a Prescription Drug Affordability Board. After years of preparatory work, the agency is poised to take its first actions on two blockbuster diabetes drugs, Jardiance and Farxiga, and a year later, the Board can expand its price control mechanism to the private insurance market. Will they clear the thicket of dysfunction in the drug marketplace and help lower actual drug costs? Sunil Dasgupta talks with Andrew York, Executive Director Maryland Prescription Drug Affordability Board, and Vincent DeMarco, president of the Maryland Health Care for All Coalition. Newly in public domain music by George Gershwin, Paul Whiteman band, and Marian Andersen.

Learn more about your ad choices. Visit megaphone.fm/adchoices

Russia's expanding nuclear arsenal, matching U.S. drug prices with Europe's, Federal agencies backing farmers' right to repair, and the fatal takeoff of UPS flight 2976. Plus, Albert Mohler on the borderless illusion, Larry the Cat at Number 10 Downing Street, and the Tuesday morning newsSupport The World and Everything in It today at wng.org/donateAdditional support comes from Pensacola Christian College. Academic excellence, biblical worldview, affordable cost. go.pcci.edu/worldFrom Ridge Haven Camp in North Carolina and Iowa. Summer Camp registration open now at ridgehaven.orgAnd from Dordt University, where the MSN–Family Nurse Practitioner program prepares nurses for Christ-centered, family-focused care. Dordt.edu

Rising drug prices impact premiums and people alike. Hear how Blue Cross Blue Shield of Michigan is putting pharmacy innovations to work to reduce costs and expand access for our members and customers.

If you've ever stood at the pharmacy counter shocked by the price of your medication, this episode is for you. From daily thyroid prescriptions to high-demand weight-loss drugs like GLP-1s, drug costs can feel unpredictable—and unfair. In this episode, we break down the new wave of “cheaper prescription” options promising to change the game.We take a closer look at Mark Cuban's Cost Plus Drugs, Amazon Pharmacy and RxPass, and the new Trump Rx pricing initiative—what they offer, how they work, and whether they actually save money on common thyroid medications and weight-loss drugs, as well as other prescription medications. We'll explain which prescriptions are most likely to benefit, where the fine print matters, and why some meds are still frustratingly expensive despite all the headlines.Whether you're managing hypothyroidism, exploring medical weight loss, or paying cash for prescriptions, this episode helps you cut through the noise. 

Learn more about your ad choices. Visit megaphone.fm/adchoices

TrumpRX is now online. The new website lists drugs at reduced rates, with coupon codes to be used at participating pharmacies or directly through manufacturers' sites. It's part of Trump's pledge to lower prescription drug prices, but health policy experts caution the impact will likely be muted for many Americans. Stephanie Sy speaks with Washington Post reporter Dan Diamond for more. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

TrumpRX is now online. The new website lists drugs at reduced rates, with coupon codes to be used at participating pharmacies or directly through manufacturers' sites. It's part of Trump's pledge to lower prescription drug prices, but health policy experts caution the impact will likely be muted for many Americans. Stephanie Sy speaks with Washington Post reporter Dan Diamond for more. PBS News is supported by - https://www.pbs.org/newshour/about/funders. Hosted on Acast. See acast.com/privacy

Jimmy addresses the latest news, like Trump launching his new prescription drug website, TrumpRx, before speaking with Halle Berry, Dylan O'Brien and Josh Safdie.

White House Correspondent Jon Decker reports President Trump has rolled out his TrumpRX website.See omnystudio.com/listener for privacy information.

White House Correspondent Jon Decker reports President Trump has rolled out his TrumpRX website.

This episode is an audio read of a Word on Benefits blog post: : https://blog.ifebp.org/pbm-rebates-explainer/ Read Jenny's post and many other great blog posts at blog.ifebp.org

Three facts are scientifically undisputed: Serotonin is essential for fetal brain development. SSRIs disrupt the serotonin system. SSRIs freely cross the placenta. So why are pregnant women being told these drugs carry "little or no risk"?In this rare head-to-head debate, Dr. Adam Urato—maternal-fetal medicine specialist and FDA expert panelist—faces off against Dr. Robert Chen, a psychiatry resident willing to do what most of his colleagues won't: step into the arena and defend the establishment position.What unfolds is a striking conversation where both physicians actually agree on more than you'd expect—including that informed consent is failing pregnant women, that the chemical imbalance theory is dead, and that "untreated depression" is a misleading frame designed to sell drugs. The uncomfortable question neither side can fully answer: If SSRIs are correcting depression, why does the research show worse outcomes for women who stay on them?This isn't anti-medication propaganda. It's the conversation your doctor isn't trained to have with you.Listen before you fill that prescription. Visit Center for Integrated Behavioral HealthDr. Roger McFillin / Radically Genuine WebsiteYouTube @RadicallyGenuineDr. Roger McFillin (@DrMcFillin) / XSubstack | Radically Genuine | Dr. Roger McFillinInstagram @radicallygenuineContact Radically GenuineConscious Clinician CollectivePLEASE SUPPORT OUR PARTNERS15% Off Pure Spectrum CBD (Code: RadicallyGenuine)10% off Lovetuner click here

Alyssa Billingsley, PharmD, joined Over the Counter to discuss the FDA's prescription to OTC transition process and what recent switches mean for independent pharmacies and their patients.

Show notes: (0:00) Intro (1:03) Dr. Garley's background and why sleep became his passion (3:14) 85% of people with sleep apnea don't know they have it (5:20) What a modern home sleep test looks like (7:17) How untreated sleep apnea shortens lifespan (12:54) Are sleep medications helping or harming you? (18:00) Magnesium and other common sleep aids (24:30) The gold standard for insomnia: CBT-I (Cognitive Behavioral Therapy for Insomnia) (26:45) What "better sleep" really means (29:51) The ideal sleep environment: cool, dark, and quiet (31:39) Do sleep trackers actually help or stress you out? (36:51) Is there a "magic" sleep window before midnight? (38:53) Morning sunlight and your body's internal clock (42:00) The real problem with phone use before bed (45:30) How to get help from Dr. Garley and The Better Sleep Clinic (46:17) Outro Who is Dr. David Garley?   Dr David Garley is a Sleep Expert and Managing Director of The Better Sleep Clinic. He originally trained in respiratory medicine and qualified as a member of the Royal College of Physicians before moving to primary care, where he continued his specialist interest in sleep medicine. He is passionate about sleep health and greatly motivated by the profound impact that the restoration of good sleep can have on the quality of life of his patients. The Better Sleep Clinic is an online sleep clinic that diagnoses and treats a wide variety of sleep disorders and specialises in obstructive sleep apnea. They offer online appointments with consultant sleep specialists and send out home sleep tests to be carried out in the comfort of your own home. Gold standard treatments for sleep disorders are provided through a friendly, patient-centred and personalised service.   Connect with Dr. Garley Website: https://www.thebettersleepclinic.co.uk/ LinkedIn: https://www.linkedin.com/in/david-garley-tbsc/?originalSubdomain=uk Links and Resources: Peak Performance Life Peak Performance on Facebook Peak Performance on Instagram  

Send us a textIn this show, the boys tackle a couple of subjects...Firstly, they discuss whether a disease of the brain causes addiction or whether it all actually begins with a poor decision.Secondly, they discuss who owns ideas? Does the intellectual property and trademarking system actually cause more problems than it actually hopes to fix?But what are your thoughts on any of these subjects? Do you agree with Tony or Tayo, or do you have different views?Tune in and listen to the discussion. Please let us have your comments on these subjects.Links used during the show:-https://www.youtube.com/watch?v=sVdaFQhS86EAlthough we much prefer effusive praise

Say no to them until your tongue bleeds. We have natural sleep aids in the Apocalypse Almanac, however.Support the show

Rapid disenrollments don't have to happen to you! Learn how better communication can smooth over most Medicare plan disenrollment issues. We outline 8 strategies that are simple for agents to implement.   Read the text version  

Pharmacist and healthcare reform advocate Leyla Ali joins us for a bold and challenging discussion that questions the foundations of modern medicine. Known as the “renegade pharmacist,” Dr. Ali argues that many commonly prescribed drugs fail to address the root causes of illness — and in some cases may do more harm than good. Drawing on her professional experience inside the pharmaceutical system, she explores the influence of Big Pharma, the importance of informed consent, and why patients must become active participants in their own health decisions.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-x-zone-radio-tv-show--1078348/support.Please note that all XZBN radio and/or television shows are Copyright © REL-MAR McConnell Meda Company, Niagara, Ontario, Canada – www.rel-mar.com. For more Episodes of this show and all shows produced, broadcasted and syndicated from REL-MAR McConell Media Company and The 'X' Zone Broadcast Network and the 'X' Zone TV Channell, visit www.xzbn.net. For programming, distribution, and syndication inquiries, email programming@xzbn.net.We are proud to announce the we have launched TWATNews.com, launched in August 2025.TWATNews.com is an independent online news platform dedicated to uncovering the truth about Donald Trump and his ongoing influence in politics, business, and society. Unlike mainstream outlets that often sanitize, soften, or ignore stories that challenge Trump and his allies, TWATNews digs deeper to deliver hard-hitting articles, investigative features, and sharp commentary that mainstream media won't touch.These are stories and articles that you will not read anywhere else.Our mission is simple: to expose corruption, lies, and authoritarian tendencies while giving voice to the perspectives and evidence that are often marginalized or buried by corporate-controlled media

In today's episode, your host, Jon LaClare, leads an important conversation that healthcare marketing rarely explains: the placebo effect and why it deserves far more attention. This discussion is inspired by the launch of Pluseebo, a transparent, intentionally humorous product designed to spark awareness around belief, expectation, and honesty in healthcare.While Pluseebo is lighthearted on the surface, its launch highlights a much deeper reality supported by published scientific research. Placebo responses can produce real, measurable biological effects in the body, including changes in brain chemistry, pain perception, and overall wellbeing. These effects are not imagined, and in many clinical trials they closely mirror the average performance of widely prescribed medications.Tune in as Jon breaks down what healthcare advertising often leaves out, including how modest the average benefit of some antidepressants, pain medications, sleep aids, and other common prescriptions can be when compared to placebo, and why side effects and transparency must be part of the conversation. Grounded in respected medical journals and FDA-reviewed data, this episode offers a research-driven perspective designed to inform, challenge assumptions, and elevate the discussion around modern healthcare. Don't miss this timely conversation on belief, biology, and why understanding the placebo effect changes how health products, treatments, and claims should be evaluated.In today's episode of the Harvest Growth Podcast, we'll cover:What the placebo effect actually is, and why it's not “fake.”What large studies reveal about SSRIs, opioids, sleep medications, anxiety medications, ADHD drugs, and statins.Why prescription drug commercials rarely tell the full storyHow transparency in healthcare affects trust and decision-makingHow Pluseebo is designed to spark honest conversations.To learn more about Pluseebo, visit Pluseebo.com.To be a guest on our next episode of the podcast, contact us today!Do you have a brand that you'd like to launch or grow? Do you want help from a partner that has successfully launched hundreds of brands totaling over $2 billion in revenues? Visit HarvestGrowth.com and set up a free consultation with us today!

It goes without saying that drug pricing and accessibility in the United States are complex indeed. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Vinay Patel, an innovative pharmacist who's set out to transform the healthcare industry, about these intricacies. Patel discusses some intriguing stories about crafting innovative solutions for employers, revitalising struggling independent pharmacies, and implementing hybrid care models that can make healthcare more attainable for everyone. The conversation touches upon how biosimilars driving pharmaceutical innovation and reducing health costs, the role of telemedicine, also. You can listen to episode 237 of the pharmaphorum podcast in the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Steve is joined by former Congressman J.D. Hayworth (R-AZ), a former member of the House Ways and Means Committee and spokesperson for the Pharmaceutical Reform Alliance, to spotlight the real cost of prescription drugs in America. He talks about PRA's interactive installation on the National Mall in Washington, D.C., where Americans are seeing firsthand how U.S. patients often pay more than three times as much for the same medications compared to other wealthy countries. Hayworth explains why transparency, competition, and common-sense reform matter, and how PRA is collecting personal stories from everyday Americans impacted by skyrocketing drug prices, putting pressure on a system that's clearly not working for patients.

Recent changes to the Postal Service's network could mean slower deliveries of prescription drugs in the mail. A study from the Brookings Institution finds 6% of Americans live far away from a brick-and-mortar pharmacy, rely heavily on mail-order prescriptions and live in areas impacted by USPS consolidation. Brookings finds nearly half of all Americans face at least one of those scenarios. USPS this year has been running trucks less often between its processing plants and post offices to transport mail and packages. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Jim MacKay reports.See omnystudio.com/listener for privacy information.

In this episode, we explore four transformative topics reshaping how we think about whole-body health:1. The Lasting Impact of Prescription Drugs on Gut HealthFrom antibiotics to acid reducers, we uncover how common medications can shift the delicate microbial balance in ways that influence digestion, metabolism, and even mental well-being.2. MIT's Discovery: An Amino Acid That Helps the Gut Heal ItselfBreakthrough science takes center stage as we examine MIT's recent findings surrounding a specific amino acid shown to support gut barrier integrity. We translate the lab data into real-world insights, exploring how this discovery could inspire future therapies. 3. Superstars for Gut–Brain Axis Health and VitalityMeet the nutrients that support a thriving communication network between your gut and brain. From Wellness Resources we spotlight the “all-stars” that keep your inner ecosystem and emotional wellness in sync. 4. Top 20 Natural Remedies Overlooked by Mainstream MedicineWe explore the history, cultural significance, and research landscape surrounding these natural options and play a clip by Dr. Eric Berg exploring what these remedies are and more importantly what they have been used for.

An Evaluation of the FDA's Proposed Removal of Fluoride Prescription Drugs from the MarketBy Spring Hatfield, RDH, BSPHOriginal article published on Today's RDH: https://www.todaysrdh.com/an-evaluation-of-the-fdas-proposed-removal-of-fluoride-prescription-drugs-from-the-market/Need CE? Start earning CE credits today at https://rdh.tv/ce Get daily dental hygiene articles at https://www.todaysrdh.com Follow Today's RDH on Facebook: https://www.facebook.com/TodaysRDH/Follow Kara RDH on Facebook: https://www.facebook.com/DentalHygieneKaraRDH/Follow Kara RDH on Instagram: https://www.instagram.com/kara_rdh/

The Friday Five for November 14, 2025: iPhone Pocket Brings Back… Pockets. CMS Rural Health Transformation Program Government Shutdown Update Most-Favored Nation Drug Pricing CMS GENEROUS Model   Get Connected:

In this episode of Disruption/Interruption, host KJ interviews Mark Mincy, Chief Commercial Officer at US RX Care, about the hidden complexities and conflicts of interest in the pharmacy benefits industry. Mark shares how his company is disrupting the status quo by demanding transparency, eliminating conflicts, and helping employers reclaim millions in savings. The conversation uncovers the tangled web of PBMs, rebates, and the urgent need for legislative and technological change. Key Takeaways: The PBM System is Riddled with Conflicts of Interest [2:34]Mark explains how pharmacy benefit managers (PBMs) and consultants often act in their own financial interest, not the employer’s or patient’s, leading to inflated drug costs. Rebates and Purchasing Contributions Inflate Drug Prices [8:59]The system of rebates and retrospective payments to PBMs can account for up to 80% of a drug’s cost, forcing manufacturers to raise prices and employers to pay more. Transparency and Fiduciary Duty are Essential for Reform [21:37]Mark’s company, US RX Care, operates with complete transparency, passes back all rebates, and offers per-member-per-month guarantees to eliminate guesswork and conflicts. Employers and Consumers Can Take Action [33:34]Mark recommends joining healthcare purchaser coalitions, hiring ERISA attorneys, and demanding non-conflicted consultants to protect interests and drive industry change. Quote of the Show [31:27]:"Everything's intertwined. You want to move and do the right thing. These employers are between a rock and a hard place, so I do think some legislative action needs to occur." – Mark Mincy Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Mark Mincy: LinkedIn: http://www.linkedin.com/in/mark-mincy-a185497 Company Website: https://us-rxcare.com How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

Starting in January, Californians will be able to buy discounted insulin from the state. That's thanks to CalRx, the state-run drug label created in 2020 that partners with manufacturers to slash generic prescription drug prices. CalRx already offers the opioid overdose reversal drug naloxone for about half the market price and other medications, including asthma inhalers, could be next. We'll talk about whether this effort could ease the prescription drug affordability crisis and bolster the supply of crucial medications. Guests: April Dembosky, health correspondent, KQED News Dr. Mariana Socal, associate professor of health policy, Johns Hopkins Bloomberg School of Public Learn more about your ad choices. Visit megaphone.fm/adchoices

Today, AFSPA Talks Prescription Drug Coverage in 2026. For the first time in a decade, we're making changes to the cost shares for prescription drugs. Join us today to talk through the changes and understand what your costs will be in 2026. See the changes at www.afspa.org/openseason. Price your drugs at www.express-scripts.com/fsbp, and be sure to select 2026. For members who have opted in to the FSBP-Express Scripts Medicare Prescription Drug Plan, or PDP, there will be NO CHANGE to cost sharing. This means that most drugs will cost members less under the PDP. Combine these savings with a wider network of pharmacies and greater flexibility for where you can obtain your maintenance drugs, and this may be the year for members who have Medicare A and/or B to opt in to the PDP. See www.afspa.org/pdp for more details and a pricing tool. You may wish to watch this episode for the slides we share to show the changes. Find the video at www.youtube.com/afspacares. Join us for AFSPA Live, a live Q&A session, on 11/20 @ 11 AM ET. We will be discussing the 2026 FSBP Open Season. If you would like to submit a question in advance, you can do so by filling out this form: https://forms.office.com/r/RApuq334NE. You can watch live on our YouTube channel @afspacares. Register for the Virtual Benefits Fair: https://vshow.on24.com/vshow/FVBF25/registration/24363 Register for an Open Season Webinar: www.afspa.org/events

Prescription drug prices can be costly. What are you supposed to do if you can't afford medication? In this episode, Dan Weissmann, host of KUOW's podcast An Arm and a Leg, shares how to find discounts on prescription medications and navigate the health care system when drugs cost more than you expected.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Prescription drug prices can be costly. What are you supposed to do if you can't afford medication? In this episode, Dan Weissmann, host of KUOW's podcast An Arm and a Leg, shares how to find discounts on prescription medications and navigate the health care system when drugs cost more than you expected.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Prescription drug prices can be costly. What are you supposed to do if you can't afford medication? In this episode, Dan Weissmann, host of KUOW's podcast An Arm and a Leg, shares how to find discounts on prescription medications and navigate the health care system when drugs cost more than you expected.Follow us on Instagram: @nprlifekitSign up for our newsletter here.Have an episode idea or feedback you want to share? Email us at lifekit@npr.orgSupport the show and listen to it sponsor-free by signing up for Life Kit+ at plus.npr.org/lifekitLearn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Friday - Clark Stinks day! Christa shares Clark Stinks posts with Clark. Submit yours at Clark.com/ClarkStinks. Also today - What are the chances of full recession, what's the extent of it  now, and how can you prepare?  There are some key steps to take.  Clark Stinks: Segments 1 & 2 Recession Planning: Segment 3 Ask Clark: Segment 4 Mentioned on the show: How To Freeze and Unfreeze Your Credit With Experian, Equifax and TransUnion Should I Freeze My Credit With the Other Credit Bureaus? Streaming TV - Clark.com Why You Need To Check Your Credit Report Today Credit Karma Review: Free Credit Score and More at Your Fingertips Axios:The 22 states close to (or in) recession Credit Card Balance Transfer Calculator Loan Payoff Calculator  /  Make A Budget - Clark.com 10 Ways To Save on Prescription Drugs 3 Reasons You Should Never Book a Nonrefundable Hotel Room Clark.com resources: Episode transcripts Community.Clark.com  /  Ask Clark Clark.com daily money newsletter Consumer Action Center Free Helpline: 636-492-5275 Learn more about your ad choices: megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Using illegal drugs is obviously a problem... just check out the DOHA cases we review every month on ClearanceJobsBlog(dot)com and News(dot)ClearanceJobs(dot)com. What we see more confusion surrounding is prescription use (+ abuse). Sean Bigley and Lindy Kyzer report on the topic. Hosted on Acast. See acast.com/privacy for more information.

For the first time in history another Medicare expert joins us (via ZOOM) to shed some light on a complicated Medicare problem: How to select the best available prescription drug plan without having to deal with any annoying insurance agents! We welcome Melinda Caughill from HeyMOE.com to explain their brand new service. MOE stands for "Medicare Open Enrollment" and Hey is a call to action (I guess) so Hey MOE should be your signal to use the best plan selection tool in the business! Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; SIMPLEST & EASIEST GUIDE EVER!" "MEDICARE DRUG PLANS: A SIMPLE D-I-Y GUIDE" "MEDICARE FOR THE LAZY MAN: BARE BONES!" For sale on Amazon.com. After enjoying the books, please consider returning to leave a short customer review to  help future readers. Official website: https://www.MedicareForTheLazyMan.com.

For the first time in history another Medicare expert joins us (via ZOOM) to shed some light on a complicated Medicare problem: How to select the best available prescription drug plan without having to deal with any annoying insurance agents! We welcome Melinda Caughill from HeyMOE.com to explain their brand new service. MOE stands for "Medicare Open Enrollment" and Hey is a call to action (I guess) so Hey MOE should be your signal to use the best plan selection tool in the business! Contact me at: DBJ@MLMMailbag.com (Most severe critic: A+)                   Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; SIMPLEST & EASIEST GUIDE EVER!" "MEDICARE DRUG PLANS: A SIMPLE D-I-Y GUIDE" "MEDICARE FOR THE LAZY MAN: BARE BONES!" For sale on Amazon.com. After enjoying the books, please consider returning to leave a short customer review to  help future readers. Official website: https://www.MedicareForTheLazyMan.com.

Facing unprecedented pressure from the Trump administration, some of the world's top drugmakers promise to cut prices. But experts say the savings might not be what they seem.Guests:Michael Cannon, Director of Health Policy Studies, Cato InstituteStacie Dusetzina, Professor of Health Policy, Vanderbilt UniversityDarius Lakdawalla, Chief Scientific Officer, USC Schaeffer CenterPete Loftus, Reporter, Wall Street JournalBen Rome, Assistant Professor of Medicine, Harvard Medical SchoolLeslie Walker, Senior Reporter, TradeoffsWe want to hear from you! Our audience survey takes less than ten minutes, and you'll be entered to win one of two $50 Bookshop.org gift cards.Learn more and read a full transcript on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Did you know that one in five adults skip filling their prescriptions because of cost, and many may be missing out on valuable savings and benefits they didn't even know they had? Tune in for an inspiring discussion with Pharmacist Joshua Fredell, Senior Vice President, Head of PBM and Specialty Product Innovation at CVS Health. Moments with Marianne Radio Show airs in the Southern California area on KMET1490AM & 98.1 FM, an ABC Talk News Radio Affiliate!  https://www.kmet1490am.comJoshua Fredell, a pharmacist and Senior Vice President, serves as Head of PBM and Specialty Product Innovation at CVS Health. He oversees ideation, commercialization, and management of the company's pharmacy benefit and specialty management products, including formulary design, network products, specialty cost management, clinical solutions, and medical benefit management. Joshua joined the legacy Caremark Rx corporation in 2003. Currently, Joshua and his team are focused on developing strategies that help create best-in-class savings while supporting clinically robust decision making including targeted formulary approaches for high-cost therapy classes, better control of specialty spend within the medical benefit, and improving the patient/provider experience while lowering overall cost. His team is also focused on continuing to innovate and enhance plan design solutions to help clients stay ahead of emerging market trends in a changing pharmaceutical landscape. Prior to CVS Health, Joshua was part of the pharmacy department of UPMC Health Plan, Joshua holds a Pharm.D. from the University of Pittsburgh.  www.cvshealth.comFor more show information visit: https://www.mariannepestana.com/

(October 01, 2025)Government shutdown begins. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about nasal spray and covid, 99% of heart disease cases have a couple key risk factors you can control, and electrolyte beverages.

In this episode of the CodeCast Podcast, Terry addresses a common misconception among medical providers: the belief that simply listing a patient's medications or repeatedly noting “continue meds” is enough to support a moderate-level evaluation and management visit, such as CPT codes 99214 or 99204. In reality, this documentation alone does not meet the criteria.= […] The post Are you documenting prescription drug management risk? (Fixed Audio) appeared first on Terry Fletcher Consulting, Inc..

In this episode of the CodeCast Podcast, Terry addresses a common misconception among medical providers: the belief that simply listing a patient's medications or repeatedly noting “continue meds” is enough to support a moderate-level evaluation and management visit, such as CPT codes 99214 or 99204. In reality, this documentation alone does not meet the criteria.= […] The post Are you documenting prescription drug management risk? appeared first on Terry Fletcher Consulting, Inc..

In this episode of the CodeCast Podcast, Terry addresses a common misconception among medical providers: the belief that simply listing a patient's medications or repeatedly noting “continue meds” is enough to support a moderate-level evaluation and management visit, such as CPT codes 99214 or 99204. In reality, this documentation alone does not meet the criteria.= […] The post Are you documenting prescription drug management risk? appeared first on Terry Fletcher Consulting, Inc..

In this episode of the CodeCast Podcast, Terry addresses a common misconception among medical providers: the belief that simply listing a patient's medications or repeatedly noting “continue meds” is enough to support a moderate-level evaluation and management visit, such as CPT codes 99214 or 99204. In reality, this documentation alone does not meet the criteria.= […] The post Are you documenting prescription drug management risk? (Fixed Audio) appeared first on Terry Fletcher Consulting, Inc..

FDA announces crackdown on misleading TV drug ads, influencers, online drug dispensaries; What's a “twisted colon”? Doctors often jump the gun in prescribing ADHD meds to young kids before behavioral fixes; A new era in skincare powered by urolithin A.

What is the Most Advertised Prescription Drug?

Alternatives to surgery for venous insufficiency; AI “hallucinates” a never-before-seen brain region in crucial test; Vegetarian complains she is prone to falling; Could tinnitus be triggered by electromagnetic fields from lighting, devices? Cannabis derivatives improve sleep where drugs fail; A novel way of treating chronic nasal infections—with snot transplants! Mitochondrial dysfunction found to be the key to heart, brain problems.

On Joe Untamed today, we dive headlong into truths the establishment wants buried. From covering the safety of prescription drugs to the CDC looking to sabotage RFK, confronting the battle for election integrity and systemic corruption head-on. With Tina Peters' unjust imprisonment still sending shockwaves nationwide, we probe the chilling question: what happens when truth-tellers are branded political prisoners, and who's orchestrating this assault on freedom? We welcome Kim Witczak, a relentless drug safety advocate whose personal loss fueled a two-decade mission to expose Big Pharma's dangerous practices. Her work has driven critical Black Box warnings, challenged FDA complacency, and revealed how profit-driven systems sideline patient safety. Kim's revelations about antidepressants, medical ethics, and regulatory failures are a must-hear for anyone who trusts their health to the system—a conversation that will open your eyes and demand action. Next we have Dr. Murray Sabrin, a fearless economist and champion of free markets, returns to unpack what the mainstream ignores: how the Federal Reserve's reckless policies, tariffs, and world trade are colliding together. With clarity and conviction, Dr. Sabrin maps out the roots of this crisis and the urgent reforms needed to reclaim financial liberty. This episode is a clarion call for patriots, families, and truth-seekers—tune in to seize the narrative and fight.